Our findings also demonstrated that MH treatment reduces CXCL2 expression, which plays a crucial role in recruiting intratumoral granulocytic MDSCs and promoting their pro-tumor immunosuppressive function (44, 80). Here, CXCL2 is linked to neoplasm.